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Integrated multi-element psychosocial interventions have 
been suggested to improve the outcomes of first-episode 
psychosis (FEP) patients, but they have been studied pri-
marily in experimental settings and in nonepidemiologically 
representative samples. Thus, we performed a cluster-ran-
domized controlled trial, comparing an integrated multi-
element psychosocial intervention, comprising cognitive 
behavioral therapy, family intervention, and case manage-
ment, with treatment as usual (TAU) for FEP patients in 
117 community mental health centers (CMHCs) in a large 
area of northern Italy (10 million inhabitants). The ran-
domized units (clusters) were the CMHCs, and the units of 
observation the patients (and, when available, their family 
members). The primary hypotheses were that add-on mul-
ticomponent intervention: (1) results in greater improve-
ments in symptoms, as assessed with positive and negative 
syndrome scale and (2) reduces in-hospital stay, based on 
days of hospitalization over the 9-month follow-up. Four 
hundred and forty-four FEP patients received the interven-
tion or TAU and were assessed at baseline and 9 months. 
Based on the retention rates of patients (and families) in 
the experimental arm, multi-element psychosocial interven-
tions can be implemented in routine mental health services. 
Regarding primary outcomes, patients in the experimental 
arm showed greater reductions in overall symptom severity, 
while no difference could be found for days of hospitaliza-
tion. Among the secondary outcomes, greater improvements 
were detected in the experimental arm for global functioning, 
emotional well-being, and subjective burden of delusions. 
No difference could be found for service disengagement and 
subjective burden of auditory hallucinations. These findings 
support feasibility and effectiveness of early interventions 
for psychosis in generalist mental health services.
Key words: schizophrenia/early psychosis/outcome 
assessment/cognitive behavioral therapy/family 
intervention
Introduction
Interest in psychosocial interventions to facilitate recov-
ery and reduce long-term disability in patients with first-
episode psychosis (FEP) has been growing.1–3 Clinical 
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guidelines for this population recommend an early and inte-
grated approach, based on psychosocial interventions.4–9
The results of multi-element interventions, including 
early detection strategies; individual, group, and family 
therapy; case management; and pharmacological treat-
ment, are promising,10 with symptom reduction, improved 
quality of life, increased social and cognitive function-
ing, lower inpatient admission rates, less in-hospital time, 
improved insight, greater treatment satisfaction, decreased 
substance abuse, and fewer self-harm episodes.11–14
However, most multi-element approaches have been 
administered to nonepidemiologically representative 
samples in (quasi-)experimental settings—rarely in epi-
demiological samples against a control15—raising the risk 
of underestimating the complexities of treating FEP in 
real-world services.16–18 In clinical practice, although some 
countries have recently implemented early psychosis 
intervention programs, most have not become routine.19 
Few studies have identified barriers that hinder feasibil-
ity of these interventions or address patient/family condi-
tions that render them ineffective or inappropriate.
There are 3 models through which early interventions 
are provided.20 The early intervention service advocated 
as the standard in the United Kingdom,21 and also in 
United States, Australia, New Zealand, and Scandinavia, 
ensuring provision of a comprehensive package by dedi-
cated and trained staff. It is resource-intensive, can result 
in the loss of a single entry point into mental health ser-
vices, and has implications for continuity of care when it 
ceases.22–25. The hub-and-spoke model comprises a central 
specialist service (“hub”) that supports existing generic 
teams. The third model involves generic services adopting 
the principles of early intervention for treating patients by 
educating the entire team. Although inexpensive,26 par-
ticularly for less resourced areas,27 this model might not 
ensure specific and optimal treatment for FEP patients.28
There are pros and cons to each model22–28 with no evi-
dence to support the superiority of any delivery; imple-
mentation of multi-element FEP-targeted interventions 
in routine services based on rigorous scientific method is 
thus necessary.29
The GET UP (Genetics, Endophenotypes, Treatment: 
Understanding early Psychosis) PIANO (Psychosis: early 
Intervention and Assessment of Needs and Outcome) 
trial30 was undertaken to assess the feasibility and effec-
tiveness of multi-element psychosocial intervention for 
FEP patients and their families in routine MH services, 
per the third delivery model, vs treatment as usual (TAU) 
in a large epidemiologically based cohort from commu-
nity mental health centers (CMHCs). Experimental treat-
ment was an adjunct to TAU, comprising: (1) cognitive 
behavioral therapy for psychosis (CBTp) to patients; (2) 
psychosis-focused family intervention (FIp) to families; 
and (3) case management (CM) to both parties. The 
intervention was provided by CMHC staff, trained in the 
previous 6 months and supervised by experts.
The primary hypotheses were that add-on multicom-
ponent intervention: (1) results in greater improvements 
in symptoms, as assessed with positive and negative syn-
drome scale (PANSS) and (2) reduces in-hospital stay, 
based on days of hospitalization over the 9-month fol-
low-up. Secondary hypotheses were that the intervention 
results in greater improvements in subjective burden of 
psychotic symptoms (auditory hallucinations and delu-
sions), social functioning and emotional well-being and 
lower service disengagement rates.
Methods
Study Design
Participation in this cluster-randomized controlled trial30 
was offered to all CMHCs located across 2 northern 
Italian regions (Veneto and Emilia-Romagna) and the 
urban areas of Florence, Milan, and Bolzano, covering 
an area of 9 951 306 inhabitants. Of 126 CMHCs, 117 
(92.8%, covering 9 304 093 inhabitants) participated.
The assignment units (clusters) were the CMHCs, and 
the units of observation and analysis were patients and 
their families.
Care Context and Participating Sites
MH care in Italy is delivered by the National Health 
Service through the Departments of Mental Health 
(DMH). In each catchment area, one or more CMHCs 
provide outpatient care, daycare, and rehabilitation to 
nearly 100 000 inhabitants (online supplementary mate-
rial, part 1). The catchment areas of rural CMHCs 
usually encompass small towns and villages, and urban 
CMHCs correspond to one or more neighborhoods.
Randomization
Stratified randomization of CMHCs was performed to 
balance differences in their characteristics (catchment 
area size, urban/mixed versus rural context) and account 
for organizational constraints (affiliation to the same 
DMH). One CMHC each in the intervention and TAU 
arms withdrew consent to participate and were excluded 
(online supplementary material, part 2).
Participants
All CMHCs were asked to refer potential psychosis cases 
at first contact during the index period to the study team. 
Based on the WHO 10-country study,31 the inclusion cri-
teria to ascertain FEP were as follows:
 • age 18–54 years,
 • residence in catchment areas of CMHCs,
 • presence of at least one of the following: hallucina-
tions, delusions, qualitative speech disorder, qualitative 













Page 3 of 12
First-Episode Psychosis: A Cluster-Randomized Trial
behavior, or two of the following: loss of interest, ini-
tiative, and drive; social withdrawal; episodic severe 
excitement; purposeless destructiveness; overwhelming 
fear; or marked self-neglect, per the WHO Screening 
Schedule for Psychosis,31
 • first lifetime contact with CMHCs, prompted by these 
symptoms.
Exclusion criteria were: (1) antipsychotic medication 
(>3 months) prescribed for an identical or similar men-
tal disorder; (2) mental disorders due to general medical 
condition; (3) moderate-severe mental retardation per a 
clinical functional assessment; and (4) psychiatric diag-
nosis other than International Classification of Diseases 
(ICD)-10 for psychosis.
All eligible patients, identified as those who reached 
the clinical stabilization, were invited to provide writ-
ten informed consent to be assessed and informed of the 
nature, scope, and possible consequences of the trial and 
that they could withdraw consent at any time. Patients were 
asked to give consent for family member assessments; fam-
ily members who agreed to participate provided written 
informed consent (online supplementary material, part 3).
The trial received approval by the ethics committees of 
the coordinating center (Azienda Ospedaliera Universitaria 
Integrata di Verona) and each participating unit and was 
registered with ClinicalTrials.gov (NCT01436331).
Diagnostic Ascertainment
Since FEP is generally a phase of high diagnostic instabil-
ity, the specific ICD-10 codes for psychosis (F1x.4; F1x.5; 
F1x.7; F20–29; F30.2, F31.2, F31.5, F31.6, F32.3, F33.3) 
were assigned at 9 months. The best-estimate ICD-10 diag-
nosis was made by consensus of a panel of clinicians by 
considering all available information on the time inter-
val from patient’s intake needed to apply the Item Group 
Checklist of the Schedule for Clinical Assessment in 
Neuropsychiatry.32
Treatments
Experimental Intervention. The intervention was pro-
vided by CMHC staff, trained in the previous 6 months 
and supervised by experts. The multi-element psychoso-
cial intervention, adjunctive to TAU, comprised: CBTp 
to patients33–36; FIp37,38 to families; and CM39 to both 
(online supplementary material, part 4).
The intervention began as soon as patients achieved 
clinical stabilization (condition in which they could col-
laborate in a brief  clinical examination) and core baseline 
measures were taken.
Treatment as Usual.  Control arm CMHCs only pro-
vided TAU, which, in Italy, comprises personalized out-
patient psychopharmacological treatment and nonspecific 
supportive clinical management by the CMHC.40,41 Family 
interventions consisted of nonspecific informal support 
sessions.
Therapist Training, Supervision, and Fidelity
Before the trial, ≥2 psychiatrists/psychologists per experi-
mental CMHC received CBTp and FIp training, and ≥1 
nurse/educator undertook CM training. At the end of 
the training, competence was assessed (score 0–50, with 
minimum 35/50 required to treat patients). Intervention 
manuals per international standards were given to the pro-
fessionals as treatment references. During intervention’s 
delivery, professionals were supported by expert psycho-
therapists assigned to each CMHC; written reports of 
each session were supervised by external experts who held 
1-day meetings every 2 months and were regularly avail-
able for consultation to ensure fidelity of the intervention. 
A random sample of sessions were audio recorded to allow 
further fidelity measurement by independent raters.42–44
Outcome Measures
The primary outcomes were assessed by the PANSS45 
for symptoms severity and case records for days of hos-
pitalization. The secondary outcomes were assessed by 
Psychotic Symptom Rating Scale (PSYRATS)46 for subjec-
tive appraisal of psychotic symptoms (auditory hallucina-
tions and delusions); Global Assessment of Functioning 
(GAF)47 for social functioning; Hamilton Rating Scale 
for Depression (HAM-D)48 for emotional well-being; 
and Verona Interview for Treatment Termination,49 case 
records, and local databases for service disengagement.
Assessment
After clinical stabilization and before treatment, core 
outcomes (PANSS, PSYRATS, GAF, HAM-D) were 
measured by 17 independent researchers.
Patients, clinicians, and raters could not be blinded to 
the trial arm. Every effort was made to preserve the rat-
ers’ independence; conflicts of interest were monitored.17
Psychosocial and pharmacological treatment data, 
number and days of hospitalizations in the 9-month fol-
low-up were also collected. Service disengagement was 
assessed by interviewing patients who interrupted contact 
with services before study termination.
Statistical Analyses
Analyses on patients’ outcomes were conducted on an 
intention-to-treat (ITT) basis. Patients meeting inclusion 
criteria, clinically stabilized, giving consent to assessment 
and assessed at baseline were analyzed in their original 
allocation regardless of the number of sessions attended. 
Missing outcome data at follow-up were described in the 
online supplementary material, part 5 and they were coped 
by addressing them with nonresponse weights. Specifically, 
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multilevel mixed-model analysis, which is the appropriate 
form as reported in the Consolidated Standards f Reporting 
Trials (CONSORT) guidelines for cluster-randomized tri-
als50 (outcomes are observed on patients [level 1], who are 
nested within CMHCs [level 2]). Estimates of the interven-
tion effect at 9-month follow-up on continuous outcomes 
were obtained with weighted random effects linear regres-
sion models (“xtreg” from Stata 11.0) with CMHC as a 
random effect and the corresponding baseline score (where 
appropriate) and the treatment assignment as fixed effects. 
With nonresponse weight method, patients with nonmiss-
ing outcome data who “look like” patients with missing 
outcome data were given greater weight in the analysis. 
Specifically, weights were constructed to be proportional 
to the inverse of the predicted probability of having non-
missing outcome data. The predicted probabilities were 
constructed by estimating a logit model of the probability 
of having nonmissing outcome data conditional on covari-
ates. The robustness of the results with respect to viola-
tion of normality was guaranteed by estimating CIs and 
P-values from 1000 bootstrap samples, using the nonpara-
metric method (Stata 11.0 “bootstrap” command). Data 
on completers (patients who were assessed at both baseline 




Overall, 626 FEP patients (364 experimental; 262 TAU) 
were eligible for the study in the recruitment phase (April 
1, 2010 to March 31, 2011) in the catchment area (Figure 1, 
bottom). A full description of the extent and nature of miss-
ing outcome data at the different stages of patients’ recruit-
ment is given in the online supplementary material, part 5.
Baseline Data. At baseline, 272 experimental arm and 
172 TAU arm patients were assessed (Table 1). 
The groups did not differ in any sociodemographic 
characteristics, except patients in the experimental group, 
with a lower mean age at first service contact. No other 
between-group differences were observed in any demo-
graphic or diagnostic variable or outcome measure.
Experimental Treatment. Most experimental group 
patients (n = 208; 76.5%) received ≥10 CBT sessions over 
the study period (Table 2), 66.3% receiving over 20 sessions.
Twenty-four (8.8%) patients did not receive any CBT 
session; 220 relatives out of 256 available (85.9%) partici-
pated in at least 1 family session. Most relatives (n = 196; 
76.6%) received ≥5 FI sessions, 140 of whom (71.4%) 
received ≥10. All experimental arm patients were assigned 
to an individual case manager and had regular contacts 
(21.7 on average). Of 272 patients, 80.1% received at least 1 
session of all 3 interventions; 220 (85.9%) family members 
received at least 1 session; CBTp could not be provided to 
2 (0.7%) patients. Thirty (11.0%) patients received CBTp 
only; out of these, 43.4% cases had no available relatives, 
23.3% did not give consent to contact relatives, 16.7% rel-
atives did not give consent for FI, 10.0% relatives dropped 
out after giving consent but before beginning FI, 3.3% 
moved, and 3.3% had incompatible working hours with 
FI appointments. For the delivery of the intervention see 
online supplementary material, part 7.
Routine Treatment Provision. Experimental arm 
patients were allowed to receive routine care, based on 
the staff’s clinical judgment. Patients and relatives in the 
experimental arm received fewer routine psychosocial 
interventions (Table 3).
Study Retention. Fifty-two (11.7%) patients dropped 
out: 33 (12.1%) and 19 (11.0%) in the experimental and 
TAU groups, respectively (not significant). There were no 
significant differences in demographic variables between 
completers and noncompleters.
Primary Outcomes. Both groups had similar base-
line clinical symptom severity patterns and experienced 
improvement in clinical measures at the 9-month follow-
up (Table  4)—more so for the experimental group in 
PANSS general psychopathology and PANSS total score, 
while PANSS negative and positive symptom subscales 
did not reach statistical significance.
With regard to PANSS items, the experimental group 
showed greater improvement in some positive (“conceptual 
disorganization” regression coefficient = −.17, P = 0.050; 
“hostility” regression coefficient = −.17, P =  .032), nega-
tive (“social withdrawal” regression coefficient  =  −0.38, 
P = .009), and general psychopathology symptoms (“pre-
occupation” regression coefficient = −.31, P = .042).
Few subjects in both arms underwent hospitalization 
in the 9 months following clinical stabilization (Table 3). 
No difference could be found in total number of days of 
hospitalization.
Secondary Outcomes. Both groups experienced 
improvement in social functioning and emotional well-
being at the 9-month follow-up—more so for the experi-
mental group in HAM-D and GAF scores.
As required by the instrument’s manual, PSYRATS 
was administered to patients scoring ≥3 on PANSS items 
of  hallucinations, delusions, unusual thought content, 
and suspiciousness. In this subgroup, during the 9-month 
period, PSYRAT Delusion Scale scores improved more 
on all items of  cognitive interpretation and emotional 
characteristic factors in the experimental group with 
respect to the TAU group. No difference could be found 
for PSYRAT Auditory Hallucination Scale, but a ten-
dency toward a greater improvement in the experimental 
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No difference could be found for service disengage-
ment rates.
Quantification of Side Effects. Registration of adverse 
events reported 4 deaths (2 car accidents in the experi-
mental group; 1 organic disease and 1 suicide in the TAU 
group) and 11 serious neurological side effects (5 in the 
TAU group and 6 in the experimental group).
Feasibility
Good feasibility of the intervention was indicated by the 
<10% dropout rate at participating sites in the experi-
mental arm; <10% of professionals in the experimental 
arm not achieving sufficient competence after an ad hoc 
training program; >50% of intervention sessions being 
considered optimal; and <20% of patients and families 
dropping out prematurely.
Representativeness of Participating CMHCs. In total, 
117 of 126 CMHCs participated in the study, and 115 
completed it.
Representativeness of Trial Subjects. A leakage study was 
undertaken at monthly intervals and on study completion 
in each CMHC to ensure accuracy of the recruitment. 
Electronic and paper information systems were scrutinized 
for cases aged 18–54 years with an ICD-10 code of psycho-
sis presenting to CMHCs for the first time during the index 
period: 18 subjects in the experimental group and 45 in the 
Eligible CMHCs (n=126) 
Population=9.951.306 
Accepted to participate (n=117) 
Population=9.304.093 
Refused to participate (n=9) 
Population=688.000 
CMHCs allocated to intervention arm (n=48) 
Population=4.573.983 
CMHCs allocated to treatment as usual arm (n=48) 
Population=4.227.110 
Eligible patients (n=364)  Eligible patients (n=262)  
Assessed at baseline (n=272; 91.3%) 
Not assessed at baseline (n=26; 8.7%) 
Received prior training for 
intervention (n=5) 
Population=503.000 
Refused to begin the study (n=1) 
Population=101.000 
Assessed at baseline (n=172; 81.1%) 
Not assessed at baseline (n=40; 18.9%) 
Assessed at follow-up (n=153; 88.9%) 
Lost to follow-up (n=19; 11.1%) 
Did not collaborate (n=1) 
Population=69.293 
Assessed at follow-up (n=239; 87.9%) 
Lost to follow-up (n=33; 12.1%) 
96 CMHCs entered the randomization 
procedure because 32 small CMHCs were 
paired and considered as 16 CMHCs 
Population=8.801.093 
Consent given (n=298; 81.9%) 
Consent not given (n=66*; 18.1%) 
Consent given (n=212; 80.9%) 
Consent not given (n=50**; 19.1%) 
Fig. 1. Trial profile. *18 from leakage study; **45 from leakage study.  
Reasons for not being assessed at baseline. Intervention arm: 7 once only contact, 2 few contacts, 15 drop out before assessment, 2 
moved; treatment as usual arm: 33 once only contact, 1 few contacts, 5 drop out before assessment, 1 moved. Reasons for not being 
assessed at follow-up. Intervention arm: 27 drop out, 1 died, 5 no consent to assessment; treatment as usual arm: 13 drop out, 2 died, 4 
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TAU group were identified as missed cases. This study thus 
confirmed the satisfactory representativeness of those who 
sought help in CMHCs of the catchment area.
Therapist Training, Supervision, and Fidelity. Ninety-
six of 105 (91.4%) professionals in the experimental 
arm completed the CBT training; 94.8% achieved the 
required competence score. Sixty-four of 72 (88.9%) pro-
fessionals completed the FI training; 96.9% achieved the 
required competence score. No difference in acquisition 
of competence by age, years from graduation, years of 
work, or theoretical orientation was noted. Supervisors 
rated the professionals’ fidelity to the manual (includ-
ing attitude, therapeutic style, and congruency with CBT 
requirements) as ranging from medium to high (paper in 
preparation).
Discussion
Service Models for FEP Patients
The GET UP PIANO trial applied innovative and tar-
geted forms of psychological interventions for FEP 
psychosis and determined their effectiveness and feasi-
bility in Italian CMHCs. Its principal challenges were to 
learn how to manage interrelated organizational factors 
of treatment provision in routine services and to imple-
ment effective interventions in routine CMHCs that are 
tailored to patients and their families. This strategy—a 
model of generic services adopting the principles of 
early intervention for FEP patients26–28—complements 
specialized stand-alone services and is a valid alterna-
tive in countries in which stand-alone services experience 
accessibility problems or cannot be implemented. Our 
novel findings provide robust empirical support of initial 
reports51,52 that FEP psychosis units can be embedded in 
generic mental health services.
A Large Pragmatic Trial
GET UP PIANO is the first FEP patients trial per-
formed in such a large catchment area, corresponding 
to nearly 10 million inhabitants and encompassing 2 
regions (Veneto and Emilia Romagna) and the metro-
politan areas of  Bolzano, Florence, and Milan. Coverage 
Table 1. Sociodemographics of Patients Assessed at Baseline (After Clinical Stabilization) and Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN)-Confirmed Diagnosis at 9 Months From Baseline
Baseline (After Clinical Stabilization)
Test and Significance  
of Difference
Treatment as Usual  
Group (n = 172)
Experimental Treatment  
Group (n = 272) 
Gender, n (%) χ2 = 1.77, df = 1, P = .184
 Male 94 (54.7%) 166 (61.0%)
 Female 78 (45.3%) 106 (39.0%)
Age at first contact with services, mean (SD) 31.5 (9.2) 29.3 (9.8) t = 2.40, df = 442, P = .017
Educational level, n (%) (13 missing) (9 missing) χ2 = 1.85, df = 1, P = .174
 Low (primary–middle school) 68 (42.8%) 95 (36.1%)
 High (secondary school, university) 91 (57.2%) 168 (63.9%)
Marital status, n (%) (12 missing) (12 missing) χ2 = 4.15, df = 2, P = .125
 Unmarried 118 (73.8%) 195 (75.0%)
 Married 27 (16.9%) 53 (20.4%)
 Widowed, separated, divorced 15 (9.3%) 12 (4.6%)
Living condition, n (%) (14 missing) (12 missing) χ2 = 1.51, df = 3, P = .680
 Alone 9 (5.7%) 14 (5.4%)
 With partner and/or children 39 (24.7%) 60 (23.0%)
 With other relatives 105 (66.5%) 182 (70.0%)
 Other 5 (3.1%) 4 (1.6%)
Working status, n (%) (4 missing) (11 missing) χ2 = 2.35, df = 3, P = .502
 Employed 64 (38.1%) 95 (36.4%)
 Unemployed 61 (36.3%) 83 (31.8%)
 Housewife, student, retired 38 (22.6%) 76 (29.1%)
 Other 5 (3.0%) 7 (2.7%)
Nationality, n (%) χ2 = 0.38, df = 1, P = .535
 Italy 149 (86.6%) 241 (88.6%)
 Othera 23 (13.4%) 31 (11.4%)
Diagnosis (SCAN-confirmed at 9 months), n (%) χ2 = 0.23, df = 1, P = .632
 Nonaffective psychosis 132 (76.7%) 214 (78.7%)
 Affective psychosis 40 (23.3%) 58 (21.3%)
Note: aStandard care: East Europe (n = 11), Africa (n = 10), South America (n = 1), Asia (n = 0), Other (n = 1); Experimental treatment: 
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of this area was ensured by careful monitoring of  the 
117 CMHCs throughout the project. Routine cases were 
examined through ongoing liaisons between research 
teams at each CMHC. This study addressed a treated 
incidence sample of  psychotic patients who made their 
first contact with public CMHCs. We know that treated 
incidence in Italy reflects the “true” incidence because 
the vast majority of  patients suffering from psychosis 
do contact public mental health services.53 Previous 
research has in fact shown that only a negligible fraction 
of  psychotic patients in Italy are treated in private hos-
pitals or practice alone and that it is a standard practice 
for general practitioners to refer all psychosis cases to 
public mental health services.54
This large epidemiologically based cohort comprised 
affective and nonaffective psychoses to reduce the prob-
ability of selection bias due to diagnostic sampling. Every 
effort was made to ensure that the experimental and TAU 
arm samples were representative of routine treatment of 
FEP patients in the study area CMHCs—eg, by perform-
ing a leakage study that assessed missing cases through-
out the procedures.
A significant challenge was to measure clinical changes 
from clinical stabilization rather than the peak of symp-
tom severity, as often done in FEP studies. Consequently, 
the magnitude of changes from intake to follow-up 
declined, but the changes in the experimental arm were 
more likely to be linked to the intervention than to non-
specific factors (including pharmacotherapy).
Feasibility
Over 90% of CMHCs asked to participate in, accepted, 
and completed the study, demonstrating high representa-
tiveness of the services and subjects and confirming that 
FEP teams can be fostered in generalist CMHCs.
Table 2. Treatment Provision in the Experimental Group During the Period Between Baseline (BL) (After Clinical Stabilization) and 
9-Month Follow-Up (FU)
Period Between BL and FU
Experimental Treatment  
Group (n = 272)
Subgroup With 0  
Sessions: Reasons, n (%)
N = 24
CBT sessions, n (%) No consent to CBT 13 (54.2%)
 0 24 (8.8%)a Drop out 4 (16.7%)
 1–4 15 (5.5%) Moved to private care 2 (8.4%)
 5–9 25 (9.2%) Moved 3 (12.5%)
 10–19 70 (25.8%) High-risk pregnancy 1 (4.1%)
 20+ 138 (50.7%) Working hours incompatible with 
appointments 1 (4.1%)
Number of CBT sessions, mean (SD), min–max 17.8 (10.3), 0–44 N = 52
Family intervention sessions, n (%) No relative available 16 (30.8%)
 0 52 (19.2%)a No consent to contact relatives 6 (11.5%)
 1–4 24 (8.8%) No consent to CBT 13 (25.0%)
 5–9 56 (20.6%) No consent to FI (given by relatives) 7 (13.5%)
 10–19 120 (44.1%) Drop out 4 (7.7%)
 20+ 20 (7.3%) Moved 3 (5.8%)
Moved to private care 2 (3.8%)
Working hours incompatible with 
appointments 1 (1.9%)
Number of FI sessions, mean (SD), min–max 9.3 (7.0), 0–36 —
Case management contacts, n (%) —
 0 0 (0.0%)
 1–4 96 (35.3%)
 5–9 40 (14.7%)
 10–19 59 (21.7%)
 20+ 77 (28.3%)
Number of CM contacts, mean (SD), min–max 21.7 (24.4), 1–120 —
Note: CBTp was based on models per Fowler et al33 and Kuipers et al34 and has demonstrated efficacy35,36 (expected delivery: ≥10 CBT 
sessions per patient in 9 months, optimally 20, with weekly sessions in the first 3 months and fortnightly thereafter). Family intervention 
(FIp) was administered per Leff  et al37 and Kuipers et al38 (expected delivery: ≥8 FIp sessions per family in 9 months, optimally 10–15: 6 
in the first 3 months and at least 1/month thereafter). To improve continuity of care, each patient/family was assigned to a case manager 
who coordinated all interventions and collaborated with therapists per Burns39 Case managers made contact with patients immediately 
after first service contact and facilitated the patient’s and family’s engagement into treatment, optimally 2–3 times/month. Each CBTp 
and FIp session and contact with the case manager were recorded using an ad hoc schedule.
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Engagement of professionals and their capacity build-
ing in specific treatments for early psychosis were high. 
No difference in acquisition of competence in admin-
istering CBTp was observed between ages, years from 
graduation, years of work, or theoretical orientation.
Further, most CMHC personnel were available to imple-
ment the add-on psychosocial interventions. Most patients 
(and relatives) accepted it, and details on the proportion of 
subjects included in different treatment intensity intervals 
were provided. These data will allow to relate “dosage” and 
outcome, thus providing further knowledge on the ongo-
ing debate as to what the “optimal dose” of psychologi-
cal intervention is, and clarify the role of individualization 
and flexibility in routine early interventions.17,54
The interventions decreased the need for nonspecific 
treatments, replaced by multi-experimental treatments, 
demonstrating the feasibility of the treatment.
Effectiveness
The multi-element intervention produced a greater symp-
tomatic improvement compared with standard care, as 
reflected by a reduction of overall symptoms level and 
general psychopathology assessed by the PANSS. This 
data show that routine CMHC activities in Italy induce 
substantial improvements, even with ordinary inter-
ventions.40,41 However, positive and negative symptoms 
showed a trend for improvement with the experimental 
treatment, which reached statistical significance only for 
some specific symptoms (such as conceptual disorgani-
zation, hostility, social withdrawal, and preoccupation). 
The lack of significant differences in positive and nega-
tive symptoms might also be due to the large improve-
ment occurred in TAU patients. It should be also said 
that the effect of early intervention on positive and nega-
tive symptoms is an inconsistent finding. In fact, our 
findings parallel those from Lambeth Early Onset11,55 and 
Croydon Outreach and Assertive Support Team56  stud-
ies, in which integrated early intervention by specialized 
services did not produce greater symptomatic improve-
ment, but contrast with those from OPUS12 and EPPIC 
(Early Psychosis Prevention and Intervention Centre).57
Unfortunately, our study could not find any difference 
on both number of hospital admissions and on length of 
Table 3. Nonspecific Interventions, Admissions, and Service Disengagement During the Period Between Baseline (BL) (After Clinical 
Stabilization) and 9-Month Follow-Up (FU)
Period Between BL and FU
Treatment as  
Usual Group (n = 172)
Experimental Treatment  
Group (n = 272)
Test and Significance  
of Difference
Nonspecific interventions
  Patients receiving  
nonspecific interventions, n (%)
66 (49.3%) (38 missing) 68 (27.3%) (23 missing) χ2 = 18.44, df = 1, P < .001
  Families receiving nonspecific  
interventions, n (%)
34 (25.4%) (38 missing) 25 (10.0%) (23 missing) χ2 = 15.72, df = 1, P < .001
Hospital admissions
 At least 1 admission, n (%) 26 (15.8%) (7 missing) 45 (16.9%) (5 missing) χ2 = 0.09, df = 1, P = .765
 Number of admissions (for admitted pts), n (%)
  1 18 (69.2%) 31 (68.9%) χ2 = 0.001, df = 1, P = .976
  >1 8 (30.8%) 14 (31.1%)
  Mean length of stay (days) (for 
admitted pts), mean (SD) [range]
23.5 (19.6) [5–75] (2 missing) 20.8 (16.0) [4–82]a (3 missing) t = .61, df = 64, P = .546
Service disengagement
 In contact with service at FU n (%) 157 (91.3%) 247 (90.8%) χ2 = 0.03, df = 1, P = .866
 Reasons for treatment discontinuation (for disengaged pts), n (%)
  Appropriate termination 4 (26.7%) 4 (16.0%) na
  Drop out 11 (73.3%) 21 (84.0%)
    Dissatisfaction with the care 
received
0 (0.0%) 1 (4.7%)
    Self-perceived clinical 
improvement
5 (45.4%) 6 (28.6%)
   Practical constraints 0 (0.0%) 2 (9.5%)
   Other reasons 1 (9.2%) 6 (28.6%)
   No answer 5 (45.4%) 6 (28.6%)
  Months from BL to the last contact 
(for disengaged pts), mean (SD)
4.6 (2.2) (1 missing) 3.3 (3.1) (1 missing) t = 1.38, df = 36, P = .177
Note: na, not applicable. Due to the low number of subjects, only descriptives are allowed.
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hospital stay, consistently with other studies with similar 
follow-up period.12,13
Regarding secondary outcomes, PSYRATS data—
which were collected (as required by the instrument’s 
guidelines) in the patient subgroup with more severe psy-
chotic symptoms—showed a significant reduction in the 
experimental group for the subjective appraisal of delu-
sions (emotional and cognitive components). This finding 
is notable because a component of the intervention, CBTp, 
is expected to specifically impact the subjective appraisal 
of distorted cognition and abnormal perceptions rather 
than symptom severity levels (like neuroleptics).58 Our 
study demonstrates that multi-element psychosocial inter-
vention has a greater beneficial effect on the amount and 
duration of preoccupation with delusions and the level 
and intensity of delusion-linked distress.
Conversely, the intervention did not show significant 
improvement in subjective appraisal for voices, consistent 
with other studies.59 One explanation is that it was not tai-
lored to patients with auditory hallucinations. Focusing 
on cognitive restructuring and beliefs about the power 
of voices—not the relationship between the voice and 
hearer60,61—might have resulted in the loss of an essen-
tial factor for change. Alternatively, there was insufficient 
focus on replacing maladaptive coping strategies with 
more adaptive approaches.62 These issues will be exam-
ined when all CBT session transcripts are analyzed.
Intervention improved global functioning in the exper-
imental arm. The largest proportion of improved func-
tioning due to the intervention was observed in subjects 
with a GAF score of 30–60, consistent with the litera-
ture12,13,55–57 and likely representing the most specific effect 
that is expected by these interventions.
The multi-element intervention reduced emotional 
distress—patients in the experimental group reported 
greater improvement in depressive symptoms, support-
ing CBT as the preferred treatment for psychological and 
emotional dysfunctions following a psychotic episode.63,64
Our findings could not provide evidence for lower rates 
of service disengagement in the experimental treatment 
group; this is probably due to the short follow-up period 
and to the fact that community-based mental health 
service organization in the whole area covered by the 
GETUP may facilitate continuity of care of people with 
severe mental disorders.
Strengths and Limitations
The GET UP PIANO trial overcomes the shortcom-
ings of  previous studies by providing a randomized 
controlled design17; a large sample size under routine 
clinical conditions in actual MH services; appropri-
ate inclusion criteria; a detailed and manualized treat-
ment protocol; and careful management of  fidelity. The 
GET UP PIANO trial has some limitations. The train-
ing of  professionals who administered the intervention 
was intensive but short; sufficient skills were gathered, 
but they should not be considered the highest quality. 
Data on the monitoring of  relapses could refer only 
to admissions as the quality of  the information on 
relapses for outpatients recorded in the case notes on a 
monthly basis, that we had foreseen in the protocol, was 
not reliable. Also, the extent of  statistically significant 
differences between groups in the scores of  the assess-
ments should be analyzed carefully and translated into 
clinically meaningful differences. The magnitude of  the 
effect size for total and general psychopathology (−0.24 
and −0.29, respectively; negative sign favors treatment 
group) was small, thus suggesting clinically significant 
changes in most (about 60%) but not in all patients 
belonging to the experimental arm.65 Two recent meta-
analyses66,67 found small effect sizes of  the CBTp effect 
on symptoms, thus suggesting that these ones are not 
the most adequate and sensitive target when evaluating 
the effects of  CBTp for psychosis. It should however 
be noted that the ITT approach used in the analyses 
has probably hampered the magnitude of  the effect. 
In fact, the predefined criterion for an optimal inter-
vention delivery was at least 20 sessions of  CBTp for 
patients and 10 sessions of  FIp for relatives, and this 
has naturalistically been satisfied only by respectively 
66.3% of  patients and 71.4% of  relatives. In a per pro-
tocol approach (paper in preparation), we expect that 
the effect sizes in favor of  the subjects who attended 
optimal doses of  the experimental intervention will 
increase, as it has been proved in other studies. Finally, 
the pragmatic design has chosen—in order to preserve 
the representativeness of  patients attending generalist 
mental health services—inclusion criteria among the 
broadest in the literature.
Due to financial constraints, the follow-up for this trial 
could not exceed 9  months: this is another significant 
limitation, as such a short study duration could hamper 
the possibility to fully exploit the effects of treatment 
in reducing hospital use—both for admission and total 
days—and might also be a reason why this study results 
are not comparable with other first-episode randomized 
studies with longer follow-up.
Conclusions
Longer follow-up in the GET UP trial is warranted to 
determine whether experimental patients will experience 
greater benefit over the long run compared with TAU 
patients. However, these findings support the feasibility 
and effectiveness of early interventions for psychosis in 
generalist mental health services.
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